These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30778391)

  • 21. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.
    Jackson BL; Adin DB; Lehmkuhl LB
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S296-305. PubMed ID: 26776587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction.
    Lu DY; Haileselassie B; Ventoulis I; Liu HY; Liang HY; Pozios I; Canepa M; Phillip S; Abraham MR; Abraham T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):101-107. PubMed ID: 28977350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral administration of pimobendan in cats with heart failure.
    Gordon SG; Saunders AB; Roland RM; Winter RL; Drourr L; Achen SE; Hariu CD; Fries RC; Boggess MM; Miller MW
    J Am Vet Med Assoc; 2012 Jul; 241(1):89-94. PubMed ID: 22720992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.
    Ward JL; Kussin EZ; Tropf MA; Tou SP; DeFrancesco TC; Keene BW
    J Vet Intern Med; 2020 Nov; 34(6):2211-2222. PubMed ID: 33026124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure.
    MacDonald KA; Kittleson MD; Larson RF; Kass P; Klose T; Wisner ER
    J Vet Intern Med; 2006; 20(5):1093-105. PubMed ID: 17063701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
    Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study.
    Araujo AQ; Arteaga E; Ianni BM; Fernandes F; Ramires FJ; Buck PC; Salemi VM; Nastari L; Mady C
    Echocardiography; 2006 Oct; 23(9):734-40. PubMed ID: 16999691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of a single dose of Aficamten (CK-274) on cardiac contractility in a A31P MYBPC3 hypertrophic cardiomyopathy cat model.
    Sharpe AN; Oldach MS; Kaplan JL; Rivas V; Kovacs SL; Hwee DT; Morgan BP; Malik FI; Harris SP; Stern JA
    J Vet Pharmacol Ther; 2023 Jan; 46(1):52-61. PubMed ID: 36382714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated left ventricular outflow tract velocities on exercise stress echocardiography may be a normal physiologic response in healthy youth.
    Wittlieb-Weber CA; Cohen MS; McBride MG; Paridon SM; Morrow R; Wasserman M; Wang Y; Stephens P
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1372-8. PubMed ID: 24139056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of left ventricular outflow tract area on systolic outflow velocity in hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study.
    Qin JX; Shiota T; Lever HM; Rubin DN; Bauer F; Kim YJ; Sitges M; Greenberg NL; Drinko JK; Martin M; Agler DA; Thomas JD
    J Am Coll Cardiol; 2002 Jan; 39(2):308-14. PubMed ID: 11788224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated-Dose Pharmacodynamics of Pimobendan in Healthy Cats.
    Sugimoto K; Sugita K; Orito K; Fujii Y
    Animals (Basel); 2022 Apr; 12(8):. PubMed ID: 35454228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular and atrial functions in hypertrophic cardiomyopathy patients with very high LVOT gradient: a speckle tracking echocardiographic study.
    Tigen K; Sunbul M; Karaahmet T; Dundar C; Ozben B; Guler A; Cincin A; Bulut M; Sari I; Basaran Y
    Echocardiography; 2014 Aug; 31(7):833-41. PubMed ID: 24341920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulsed tissue Doppler imaging in normal cats and cats with hypertrophic cardiomyopathy.
    Koffas H; Dukes-McEwan J; Corcoran BM; Moran CM; French A; Sboros V; Simpson K; McDicken WN
    J Vet Intern Med; 2006; 20(1):65-77. PubMed ID: 16496925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Prasad M; Geske JB; Sorajja P; Ommen SR; Schaff HV; Gersh BJ; Nishimura RA
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):962-970. PubMed ID: 27062082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy.
    MacDonald KA; Kittleson MD; Kass PH; White SD
    J Vet Intern Med; 2008; 22(2):335-41. PubMed ID: 18346145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intraventricular obstructions in dobutamine stress echocardiography: determinants of their development and clinical sequelae].
    Wagner S; Mohr-Kahaly S; Nixdorff U; Kuntz S; Menzel T; Kölsch B; Meinert R; Meyer J
    Z Kardiol; 1997 May; 86(5):327-35. PubMed ID: 9304307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease.
    Fox PR; Liu SK; Maron BJ
    Circulation; 1995 Nov; 92(9):2645-51. PubMed ID: 7586368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.